 Todd Getz
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 18 | 2022 | 386 | 3.640 |
Why?
| | Blood Preservation | 7 | 2022 | 271 | 1.630 |
Why?
| | Cryopreservation | 3 | 2022 | 94 | 1.090 |
Why?
| | Platelet Aggregation | 6 | 2020 | 97 | 1.060 |
Why?
| | Hemostasis | 5 | 2023 | 80 | 0.690 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2013 | 443 | 0.680 |
Why?
| | Protein-Tyrosine Kinases | 3 | 2013 | 431 | 0.660 |
Why?
| | Suntan | 1 | 2019 | 1 | 0.630 |
Why?
| | Platelet Transfusion | 2 | 2020 | 61 | 0.630 |
Why?
| | Platelet Membrane Glycoproteins | 5 | 2013 | 36 | 0.590 |
Why?
| | Wounds and Injuries | 7 | 2024 | 711 | 0.510 |
Why?
| | Bleeding Time | 2 | 2015 | 7 | 0.490 |
Why?
| | Saphenous Vein | 2 | 2015 | 32 | 0.490 |
Why?
| | Blood Transfusion | 4 | 2024 | 298 | 0.460 |
Why?
| | Receptors, Thrombin | 2 | 2013 | 13 | 0.440 |
Why?
| | Vascular System Injuries | 1 | 2015 | 73 | 0.430 |
Why?
| | Dextran Sulfate | 1 | 2013 | 79 | 0.410 |
Why?
| | Blood Coagulation | 4 | 2019 | 239 | 0.400 |
Why?
| | Shock, Hemorrhagic | 2 | 2024 | 165 | 0.370 |
Why?
| | Threonine | 2 | 2010 | 44 | 0.370 |
Why?
| | Blood Component Removal | 2 | 2022 | 24 | 0.360 |
Why?
| | Flow Cytometry | 5 | 2019 | 1158 | 0.350 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 353 | 0.350 |
Why?
| | Myosin Light Chains | 1 | 2010 | 26 | 0.350 |
Why?
| | Carbazoles | 1 | 2011 | 83 | 0.340 |
Why?
| | Plateletpheresis | 3 | 2022 | 27 | 0.340 |
Why?
| | Serine | 1 | 2010 | 137 | 0.330 |
Why?
| | Apoptosis | 1 | 2019 | 2488 | 0.330 |
Why?
| | ABO Blood-Group System | 2 | 2024 | 39 | 0.280 |
Why?
| | Platelet Activation | 6 | 2015 | 91 | 0.280 |
Why?
| | Cold Temperature | 2 | 2020 | 155 | 0.270 |
Why?
| | Registries | 2 | 2024 | 1902 | 0.250 |
Why?
| | Thromboplastin | 2 | 2015 | 70 | 0.240 |
Why?
| | Resuscitation | 2 | 2024 | 238 | 0.230 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 591 | 0.230 |
Why?
| | Pulmonary Embolism | 2 | 2024 | 212 | 0.220 |
Why?
| | Syk Kinase | 3 | 2013 | 21 | 0.220 |
Why?
| | Lectins, C-Type | 3 | 2013 | 71 | 0.210 |
Why?
| | Thrombosis | 2 | 2015 | 348 | 0.180 |
Why?
| | Trauma Centers | 1 | 2024 | 402 | 0.180 |
Why?
| | Venous Thrombosis | 2 | 2024 | 176 | 0.170 |
Why?
| | Ticlopidine | 3 | 2015 | 52 | 0.170 |
Why?
| | Venous Thromboembolism | 1 | 2024 | 287 | 0.170 |
Why?
| | Mice, Knockout | 7 | 2018 | 2887 | 0.170 |
Why?
| | Thrombelastography | 2 | 2019 | 150 | 0.170 |
Why?
| | Quinolines | 1 | 2020 | 156 | 0.160 |
Why?
| | Humans | 27 | 2024 | 129527 | 0.160 |
Why?
| | Isoenzymes | 2 | 2011 | 300 | 0.150 |
Why?
| | Platelet Count | 1 | 2019 | 82 | 0.150 |
Why?
| | Factor IX | 2 | 2018 | 43 | 0.150 |
Why?
| | Hemostatics | 1 | 2019 | 50 | 0.150 |
Why?
| | Protein Kinase C | 2 | 2011 | 261 | 0.150 |
Why?
| | Protein S | 1 | 2018 | 5 | 0.150 |
Why?
| | Factor IXa | 1 | 2018 | 16 | 0.150 |
Why?
| | Hemophilia B | 1 | 2018 | 48 | 0.140 |
Why?
| | Hemorrhage | 2 | 2023 | 680 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 539 | 0.140 |
Why?
| | Primary Graft Dysfunction | 1 | 2017 | 29 | 0.140 |
Why?
| | Military Personnel | 1 | 2024 | 518 | 0.140 |
Why?
| | Lactic Acid | 1 | 2019 | 304 | 0.140 |
Why?
| | Calcium | 3 | 2013 | 1208 | 0.140 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2015 | 441 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2023 | 521 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 253 | 0.130 |
Why?
| | Refrigeration | 1 | 2016 | 11 | 0.130 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 24 | 0.130 |
Why?
| | Solutions | 1 | 2016 | 151 | 0.120 |
Why?
| | Quality Improvement | 1 | 2024 | 1103 | 0.120 |
Why?
| | rap1 GTP-Binding Proteins | 1 | 2015 | 4 | 0.120 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2015 | 3 | 0.120 |
Why?
| | Talin | 1 | 2015 | 8 | 0.120 |
Why?
| | Platelet Adhesiveness | 1 | 2015 | 14 | 0.120 |
Why?
| | Time Factors | 4 | 2024 | 6530 | 0.120 |
Why?
| | Microscopy, Video | 1 | 2015 | 25 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 68 | 0.120 |
Why?
| | Intravital Microscopy | 1 | 2015 | 25 | 0.120 |
Why?
| | GTPase-Activating Proteins | 1 | 2015 | 80 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 5468 | 0.110 |
Why?
| | Fibrinogens, Abnormal | 1 | 2014 | 4 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2013 | 0.110 |
Why?
| | Fibrin | 1 | 2015 | 70 | 0.110 |
Why?
| | Phosphorylation | 4 | 2013 | 1714 | 0.110 |
Why?
| | Skin | 1 | 2019 | 724 | 0.110 |
Why?
| | Peptides, Cyclic | 2 | 2013 | 256 | 0.110 |
Why?
| | Glucose | 1 | 2019 | 996 | 0.110 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.110 |
Why?
| | Mitochondria | 2 | 2019 | 876 | 0.110 |
Why?
| | Fibrinogen | 1 | 2014 | 164 | 0.100 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 397 | 0.100 |
Why?
| | Laser Therapy | 1 | 2015 | 129 | 0.100 |
Why?
| | Signal Transduction | 5 | 2013 | 4916 | 0.100 |
Why?
| | Bacteria | 1 | 2019 | 812 | 0.100 |
Why?
| | Polysaccharides | 1 | 2013 | 86 | 0.100 |
Why?
| | Animals | 11 | 2018 | 35334 | 0.100 |
Why?
| | Tyrosine | 1 | 2013 | 222 | 0.100 |
Why?
| | Arteries | 1 | 2014 | 266 | 0.100 |
Why?
| | Mice | 9 | 2015 | 16973 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 184 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2019 | 4087 | 0.090 |
Why?
| | Protein Binding | 2 | 2018 | 2121 | 0.090 |
Why?
| | Peptides | 3 | 2011 | 925 | 0.090 |
Why?
| | Cell Shape | 1 | 2010 | 56 | 0.090 |
Why?
| | Male | 12 | 2024 | 63586 | 0.090 |
Why?
| | Adenosine Diphosphate | 1 | 2010 | 78 | 0.090 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 477 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2016 | 864 | 0.080 |
Why?
| | Liver Transplantation | 1 | 2017 | 833 | 0.080 |
Why?
| | Kinetics | 2 | 2010 | 1641 | 0.080 |
Why?
| | rho-Associated Kinases | 1 | 2010 | 85 | 0.080 |
Why?
| | Amino Acids, Aromatic | 1 | 2009 | 8 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2011 | 740 | 0.080 |
Why?
| | Collagen Type IV | 1 | 2009 | 23 | 0.080 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2010 | 164 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1091 | 0.080 |
Why?
| | Female | 11 | 2024 | 68650 | 0.080 |
Why?
| | Calcium Signaling | 1 | 2011 | 251 | 0.080 |
Why?
| | Protein Kinase C-delta | 1 | 2009 | 44 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 342 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4073 | 0.070 |
Why?
| | Adult | 7 | 2024 | 35505 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2017 | 2475 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2024 | 14532 | 0.060 |
Why?
| | Inflammation | 2 | 2014 | 2741 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 885 | 0.060 |
Why?
| | United States Department of Defense | 1 | 2024 | 12 | 0.060 |
Why?
| | Middle Aged | 6 | 2024 | 31087 | 0.050 |
Why?
| | Thrombin | 2 | 2015 | 147 | 0.050 |
Why?
| | Blood Component Transfusion | 1 | 2024 | 83 | 0.050 |
Why?
| | Warfare | 1 | 2023 | 65 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2024 | 510 | 0.050 |
Why?
| | Thrombocytopenia | 2 | 2015 | 189 | 0.050 |
Why?
| | Benzothiazoles | 1 | 2020 | 32 | 0.040 |
Why?
| | Plasma | 1 | 2022 | 206 | 0.040 |
Why?
| | Aged | 4 | 2024 | 22063 | 0.040 |
Why?
| | Survival Rate | 1 | 2024 | 1870 | 0.040 |
Why?
| | Freeze Drying | 1 | 2019 | 82 | 0.040 |
Why?
| | Coagulants | 1 | 2018 | 15 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2018 | 206 | 0.040 |
Why?
| | Dental Anxiety | 1 | 1997 | 3 | 0.030 |
Why?
| | Anesthesia, Local | 1 | 1997 | 16 | 0.030 |
Why?
| | Risk Factors | 2 | 2024 | 9779 | 0.030 |
Why?
| | Anesthesia, Dental | 1 | 1997 | 22 | 0.030 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2018 | 139 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 402 | 0.030 |
Why?
| | Injections | 1 | 1997 | 171 | 0.030 |
Why?
| | Postoperative Period | 1 | 2017 | 329 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2019 | 663 | 0.030 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2015 | 6 | 0.030 |
Why?
| | Thrombopoiesis | 1 | 2015 | 8 | 0.030 |
Why?
| | Lymphopenia | 1 | 2015 | 60 | 0.030 |
Why?
| | Splenectomy | 1 | 2015 | 58 | 0.030 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2015 | 63 | 0.030 |
Why?
| | Binding Sites | 1 | 2018 | 1250 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 60 | 0.030 |
Why?
| | Antithrombins | 1 | 2014 | 58 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5429 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2015 | 173 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 427 | 0.020 |
Why?
| | Cell Survival | 1 | 2016 | 1084 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2013 | 154 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2014 | 392 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1950 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2013 | 94 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2013 | 218 | 0.020 |
Why?
| | Length of Stay | 1 | 2017 | 1132 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1248 | 0.020 |
Why?
| | Hemophilia A | 1 | 2013 | 115 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 206 | 0.020 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 231 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2013 | 333 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 29 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2013 | 398 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 109 | 0.020 |
Why?
| | Phenylalanine | 1 | 2009 | 65 | 0.020 |
Why?
| | Thromboxane A2 | 1 | 2009 | 11 | 0.020 |
Why?
| | Protein Kinase C-theta | 1 | 2009 | 1 | 0.020 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2009 | 2 | 0.020 |
Why?
| | Qa-SNARE Proteins | 1 | 2009 | 14 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 137 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 232 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2015 | 889 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3181 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 637 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 875 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2009 | 438 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2135 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 260 | 0.020 |
Why?
| | United States | 1 | 2024 | 13865 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3702 | 0.020 |
Why?
| | Antibodies | 1 | 2009 | 398 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2055 | 0.020 |
Why?
| | Gene Expression | 1 | 2010 | 1461 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2827 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2009 | 695 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 10232 | 0.010 |
Why?
| | Neoplasms | 1 | 2015 | 2450 | 0.010 |
Why?
| | Manifest Anxiety Scale | 1 | 1997 | 4 | 0.010 |
Why?
| | Escape Reaction | 1 | 1997 | 62 | 0.010 |
Why?
| | Disease Transmission, Infectious | 1 | 1997 | 55 | 0.010 |
Why?
| | Avoidance Learning | 1 | 1997 | 71 | 0.010 |
Why?
| | Anesthetics, Local | 1 | 1997 | 79 | 0.010 |
Why?
| | Pain Measurement | 1 | 1997 | 507 | 0.010 |
Why?
| | Data Collection | 1 | 1997 | 649 | 0.010 |
Why?
| | Pain | 1 | 1997 | 788 | 0.010 |
Why?
| | Cognition | 1 | 1997 | 1125 | 0.000 |
Why?
| | Adolescent | 1 | 1997 | 20409 | 0.000 |
Why?
|
|
Getz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|